10-Year Journey Through Brain Gliomas: Case Report

1. Wesseling P, Capper D. WHO 2016 Classification of gliomas. Neuropathology and Applied Neurobiology. 2018;44:139-150.10.1111/nan.1243228815663Search in Google Scholar

2. Louis DN, Perry A, Reifenberger G, et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol. 2016;131(6):803-820.10.1007/s00401-016-1545-127157931Search in Google Scholar

3. Claus EB, Walsh KM, Wiencke JK, et al. Survival and low-grade glioma: the emergence of genetic information. Neurosurg Focus. 2015;38(1):E6.10.3171/2014.10.FOCUS12367436102225552286Search in Google Scholar

4. Duffau H, Taillandier L. New concepts in the management of diffuse low-grade glioma: Proposal of a multistage and individualized therapeutic approach. Neuro Oncol. 2015;17(3):332-342.10.1093/neuonc/nou153Search in Google Scholar

5. Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system [published correction appears in Acta Neuropathol. 2007 Nov;114(5):547]. Acta Neuropathol. 2007;114(2):97-109.10.1007/s00401-007-0243-4192916517618441Search in Google Scholar

6. Merrell, R. T., Quant, E. C., & Wen, P. Y. (2010). Advances in Treatment Options for High-grade Glioma—Current Status and Future Perspectives. US Neurology, 06(01), 55.10.17925/USN.2010.06.01.55Search in Google Scholar

7. Walid MS. Prognostic factors for long-term survival after glioblastoma. Perm J. 2008;12(4):45-48.10.7812/TPP/08-027303714021339920Search in Google Scholar

8. Tamimi AF, Juweid M. Epidemiology and Outcome of Glioblastoma. In: De Vleeschouwer S, editor. Glioblastoma. Brisbane (AU): Codon Publications; 2017 Sep 27. Chapter 8.10.15586/codon.glioblastoma.2017.ch829251870Search in Google Scholar

9. Săceleanu V. Neurochirurgie Clinică, Edit. ULBS Sibiu; 2014.Search in Google Scholar

10. Hanif F, Muzaffar K, Perveen K, Malhi SM, Simjee ShU. Glioblastoma Multiforme: A Review of its Epidemiology and Pathogenesis through Clinical Presentation and Treatment. Asian Pac J Cancer Prev. 2017;18(1):3-9.Search in Google Scholar

11. Gîţă IE. Implications for language acquisition theories: a fresh look at the “genie case”. Revista Transilvania. 2016;12:57-60.Search in Google Scholar

12. Kobyakov GL, Absalyamova OV, Poddubskiy AA, Lodygina KS, Kobyakova EA. Klassifikatsiia VOZ pervichnykh opukholeĭ tsentral’noĭ nervnoĭ sistemy 2016 g.: vzgliad klinitsista [The 2016 WHO classification of primary central nervous system tumors: a clinician’s view]. Zh Vopr Neirokhir Im N N Burdenko. 2018;82(3):88-96.10.17116/neiro20188238829927430Search in Google Scholar

13. Huang J, Yu J, Tu L, Huang N, Li H, Luo Y. Isocitrate Dehydrogenase Mutations in Glioma: From Basic Discovery to Therapeutics Development. Front Oncol. 2019;9:506.10.3389/fonc.2019.00506658481831263678Search in Google Scholar

14. Cindea C, Mihaila R, Saceleanu, V. Thrombosis Generation Abnormalities In Spontaneous Intracerebral Haemorrhage. Romanian Neurosurgery. 2009;33.Search in Google Scholar

15. Cavalu S, et al. Eco-friendly, Facile and Rapid Way for Synthesis of Selenium Nanoparticles production, structural and morphological characterisation. Revista de Chimie. 2017;68(12):2963-2966.10.37358/RC.17.12.6017Search in Google Scholar